Monopar Therapeutics Inc.
MNPR
$113.04
$2.632.38%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 134.30M | 137.49M | 140.40M | 143.68M | 53.25M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 464.70K | 250.90K | 63.70K | 414.80K | 497.30K |
| Total Current Assets | 134.76M | 137.74M | 140.46M | 144.09M | 53.75M |
|
|
|||||
| Total Current Assets | 134.76M | 137.74M | 140.46M | 144.09M | 53.75M |
| Net Property, Plant & Equipment | 215.10K | 239.90K | 254.90K | 106.70K | 118.20K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 134.98M | 137.98M | 140.72M | 144.20M | 53.87M |
|
|
|||||
| Total Accounts Payable | 3.92M | 2.36M | 2.64M | 2.54M | 1.55M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 97.80K | 98.90K | 90.60K | 31.40K | 33.40K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 4.02M | 2.46M | 2.74M | 2.57M | 1.58M |
|
|
|||||
| Total Current Liabilities | 4.02M | 2.46M | 2.74M | 2.57M | 1.58M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 107.80K | 131.60K | 154.90K | 70.90K | 80.40K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00 | -- | -- | -- | -- |
| Total Liabilities | 4.12M | 2.59M | 2.89M | 2.64M | 1.66M |
|
|
|||||
| Common Stock & APIC | 229.48M | 228.70M | 227.21M | 225.85M | 133.00M |
| Retained Earnings | -98.72M | -93.40M | -89.51M | -84.31M | -80.87M |
| Treasury Stock & Other | 91.30K | 98.50K | 131.40K | 11.70K | 77.60K |
| Total Common Equity | 130.86M | 135.39M | 137.83M | 141.56M | 52.20M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 130.86M | 135.39M | 137.83M | 141.56M | 52.20M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 130.86M | 135.39M | 137.83M | 141.56M | 52.20M |
|
|
|||||